Browsing Tag
Thermo Fisher Scientific
34 posts
The new engine of drug discovery? Inside Thermo Fisher Scientific’s cryo-EM hub in the Bay Area
Thermo Fisher Scientific opens a cryo-EM drug discovery center in South San Francisco to accelerate structural biology research. Discover why this matters for pharma.
Why Thermo Fisher Scientific (NASDAQ: TMO) is spending US$9.4bn on Clario to dominate clinical-trial analytics
Find out how Thermo Fisher’s US$9.4 billion acquisition of Clario is reshaping the clinical-trial services industry and what it means for investors.
Inside Thermo Fisher Scientific’s plan to harness OpenAI for faster, smarter biotech innovation
Find out how Thermo Fisher Scientific plans to use OpenAI’s generative AI to revolutionize research speed, accuracy, and discovery across life sciences.
Can Thermo Fisher’s new molecular test transform lung transplant care with faster rejection detection?
Discover how Thermo Fisher’s new AI-based MMDx Lung test improves early detection of lung transplant rejection and reshapes transplant diagnostics.
Vaxcyte’s $1bn Thermo Fisher deal: Can new U.S. vaccine capacity secure its PCV future?
Vaxcyte partners with Thermo Fisher in a $1B deal to build U.S. fill-finish vaccine capacity. Find out why this matters for its PCV pipeline and investors.
Thermo Fisher wins FDA approval for next-generation sequencing companion diagnostic tied to new HER2-mutant NSCLC therapy
Thermo Fisher wins FDA approval for its Oncomine Dx Target Test as a companion diagnostic for Boehringer Ingelheim’s new HER2-mutant NSCLC therapy.
Stablepharma’s fridge-free vaccine breakthrough: Dr Karen O’Hanlon explains the StablevaX journey
Find out how Stablepharma’s SPVX02 could redefine global vaccine logistics with fridge-free technology. Dr Karen O’Hanlon explains the science behind StablevaX™.
What is the Luma platform by Dotmatics and why is Siemens betting on it for life sciences R&D?
Explore how Luma by Dotmatics stacks up against Benchling and Thermo Fisher in AI-powered scientific R&D. Is Siemens building a new category?
Healthcare Global Enterprises Q4 FY25: Revenue rises 16% ahead of KKR’s $400m stake closure
Healthcare Global posts 16% revenue growth in FY25; KKR’s $400M controlling stake to close in Q3 2025. Read how HCG is transforming oncology care.
Stablepharma begins world’s first fridge-free vaccine trials; Is the cold chain era ending?
Stablepharma launches the first-ever fridge-free vaccine trial for tetanus and diphtheria—SPVX02—potentially reshaping global vaccine distribution forever.